Literature DB >> 33045214

Evolutionary conservation of long non-coding RNAs in non-alcoholic fatty liver disease.

Sumati Rohilla1, Ankita Awasthi1, Savneet Kaur2, Rekha Puria3.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of conditions ranging from hepatic steatosis to steatohepatitis (NASH) to fibrosis in the absence of alcohol consumption. Its pathogenesis involves both genetic and environmental factors with a multitude of underlying molecular mechanisms and mediators at each stage. Recent transcriptomic-based studies have led to the identification and association of long non-coding RNAs (lncRNAs) with disease pathology in NAFLD patients and in vivo rodent models. However, the knowledge of function of most of the lncRNAs in NAFLD pathology remains obscure. In the current review, we give a comprehensive catalogue of well reported lncRNAs in NAFLD and classify them using sequence and synteny-based evolutionary conservation across rodents, nonhuman primate and human species. The conserved lncRNAs across all the three species may be dissected in larger clinical studies of NAFLD and can be explored as biomarkers and therapeutic targets. In addition, we also review and analyse single nucleotide polymorphisms (SNPs) in these lncRNAs. It adds another facet to the regulatory role of NAFLD-associated lncRNAs and underscores the significance of a novel genetic landscape of non-coding genome in determining the genetic susceptibility of NAFLD.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Conservation; Humans; NAFLD; NHPs; Rodents; SNP; lncRNA

Mesh:

Substances:

Year:  2020        PMID: 33045214     DOI: 10.1016/j.lfs.2020.118560

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Knockdown of LncRNA NEAT1 inhibits myofibroblast activity in oral submucous fibrosis through miR-760/TPM1 axis.

Authors:  Wei Li; Bin Cheng
Journal:  J Dent Sci       Date:  2021-12-08       Impact factor: 3.719

2.  Upregulated lncRNA HCG18 in Patients with Non-Alcoholic Fatty Liver Disease and Its Regulatory Effect on Insulin Resistance.

Authors:  Yu Xia; Yanxia Zhang; Huiyun Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-12-03       Impact factor: 3.168

Review 3.  Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.

Authors:  Eirini Martinou; Marinos Pericleous; Irena Stefanova; Vasha Kaur; Angeliki M Angelidi
Journal:  Diagnostics (Basel)       Date:  2022-02-04

4.  Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.

Authors:  Xiaomeng Chen; Hong Ma; Yan Gao; Ye Jin; Wei Ning; Yue Hou; Jianrong Su
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Identifying Autophagy-Related lncRNAs and Potential ceRNA Networks in NAFLD.

Authors:  Ziyi Cao; Li Guan; RunZhi Yu; Jie Chen
Journal:  Front Genet       Date:  2022-06-30       Impact factor: 4.772

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.